These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7677679)

  • 1. Maternal serum screening and routine 18-week ultrasound in the detection of all chromosomal abnormalities.
    Scott F; Boogert A; Smart S; Anderson J
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):165-8. PubMed ID: 7677679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal abnormalities detected after an abnormal ultrasound in pregnancy.
    Meagher S; Renshaw R; Smith A; Milligan J
    Clin Exp Obstet Gynecol; 1994; 21(4):215-20. PubMed ID: 7994869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for fetal anomalies by ultrasound at 14 and 21 weeks.
    D'Ottavio G; Meir YJ; Rustico MA; Pecile V; Fischer-Tamaro L; Conoscenti G; Natale R; Mandruzzato GP
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):375-80. PubMed ID: 9476319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonographic scoring index for prenatal detection of chromosomal abnormalities.
    Benacerraf BR; Neuberg D; Bromley B; Frigoletto FD
    J Ultrasound Med; 1992 Sep; 11(9):449-58. PubMed ID: 1283415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The advantages of using triple-marker screening for chromosomal abnormalities.
    Kellner LH; Weiss RR; Weiner Z; Neuer M; Martin GM; Schulman H; Lipper S
    Am J Obstet Gynecol; 1995 Mar; 172(3):831-6. PubMed ID: 7534448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for fetal chromosomal abnormalities by maternal serum biochemistry and ultrasound examination of fetal morphology.
    Hecher K; Snijders R; Nicolaides K
    Curr Opin Obstet Gynecol; 1993 Apr; 5(2):170-8. PubMed ID: 7683916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of routine prenatal ultrasound examination in detecting fetal chromosomal abnormalities in a low risk population.
    Stoll C; Dott B; Alembik Y; Roth MP
    Hum Genet; 1993 Mar; 91(1):37-41. PubMed ID: 8454285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.
    Merkatz IR; Nitowsky HM; Macri JN; Johnson WE
    Am J Obstet Gynecol; 1984 Apr; 148(7):886-94. PubMed ID: 6201071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indication-specific accuracy of second-trimester genetic ultrasonography for the detection of trisomy 21.
    Vintzileos AM; Guzman ER; Smulian JC; Day-Salvatore DL; Knuppel RA
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1045-8. PubMed ID: 10561615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal screening for chromosome abnormalities.
    Chitty L
    Br Med Bull; 1998; 54(4):839-56. PubMed ID: 10367418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An artificial intelligent diagnostic system with neural networks to determine genetical disorders and fetal health by using maternal serum markers.
    Beksaç MS; Durak B; Ozkan O; Cakar AN; Balci S; Karakaş U; Laleli Y
    Eur J Obstet Gynecol Reprod Biol; 1995 Apr; 59(2):131-6. PubMed ID: 7544745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
    Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
    BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
    Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound screening for fetal abnormalities.
    Chitty LS
    Prenat Diagn; 1995 Dec; 15(13):1241-57. PubMed ID: 8710765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.